Govt Job: For M.Pharm or MSc for Senior Research Fellow at CARI

The research institute, established in the year 1973 and renamed Central Ayurveda Research Institute in Dec 2020, is engaged in research with the focus mandate, conduct medicine-botanical exploration in parts of Central India.

Collect and supply genuine raw drug materials for R&D work To build up repositories for medicinal plants and crude drugs.

To establish an herbal garden and carry out the cultivation of medicinal plants for Ayurveda.

Post: Senior Research Fellow

A walk-in interview for 04 posts of Senior Research Fellow (SRF) Chemistry will be held at Central Ayurveda Research Institute, Jhansi.

A postgraduate degree in Chemistry or Chemical Sciences is required, as well as 2 years of experience. M.Pharma (Pharmaceutical Chemistry) from a reputable university or institution

Desirable: Preference will be given to candidates having experience in ASU&H drugs analysis including handling instruments like HPTLC/ HPLC/ LC-MS/ GC-MS/ ICPOES etc. and Publications in SCI Indexing Journals with article writing skills.

Preclinical Standardization and Development of SOP for Coated Tablets from Amlaki, Guduchi, and Vasa Aqueous and Hydroalcoholic Extracts, as well as Shelf-life Studies.”

Duration: One (1) Year

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

Effect of geographical variations, phytochemical profiling, and marker-based quantification of selected medicinally important Ficus species

Duration: Two (2) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

QC Analysis, Estimation of Markers/PRS & Shelf-life Studies of Ayush PTK and Go-Mutra Haritaki

Duration : Three and a Half (3.5) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

Development of Quality Standards, Estimation of Markers, and Shelf-Life Study of Ayush-82 and Ayush-SG

Duration: Three (3) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

General Terms and Conditions:
1. The engagement would be strictly contractual in nature and would run concurrently with the project; no claim for continuation of regular appointments will be considered.

2. The eligibility of candidates in respect of age will be determined as of 01.01.2022 & Relaxation in age for SC/ST/OBC etc. candidates as per Govt, of India Rules.

3. No TAD A will be paid for attending the interview.

Walk-in-Interview: 09.11.2022 at 9.30 AM onwards at Central Ayurveda Research Institute, Jhansi

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’